Gan & Lee Pharmaceuticals Co., Ltd. Class ASSE: 603087

Announcement on Convening the Q3 2025 Performance Briefing

Oct 25, 2025 · Issued by Gan & Lee Pharmaceuticals Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Convening the Q3 2025 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment